Literature DB >> 23784736

Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case series.

Bedriye Öncü1, Okan Er, Burçin Çolak, David J Nutt.   

Abstract

Attention deficit-hyperactivity disorder (ADHD) is frequently comorbid with mood disorders in both children and adults. Comorbidity is shown to have negative consequences and it needs to be treated effectively. Lamotrigine, an anticonvulsant indicated for the maintenance treatment of bipolar depression is reported to be effective in adult ADHD comorbid with bipolar II disorder. We conducted a retrospective chart review to identify patients with adult ADHD and comorbid mood disorders on lamotrigine, along with ADHD medications, and/or antidepressants and antipsychotics. We identified 40 patients (17 women, 42.5%; age range 16 - 55 yrs), 50% with bipolar II and 50% with recurrent depression. Their treatment response was evaluated by Clinical Global Impression scales. We found that 31 patients (77.5%) improved with lamotrigine, there was no change in 7 patients (17.5%) and 2 patients got worse, with a mean lamotrigine dose of 125.6 ± 47.8 mg (25 - 250 mg). To our knowledge, this is the first study to report that lamotrigine might be a safe and effective treatment option for adult ADHD comorbid with bipolar and recurrent depression.

Entities:  

Keywords:  Adult ADHD; attention deficit-hyperactivity disorder; bipolar disorder; comorbidity; depression; effectiveness; lamotrigine; mood disorders; pharmacotherapy; safety

Mesh:

Substances:

Year:  2013        PMID: 23784736     DOI: 10.1177/0269881113493365

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

Review 1.  What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.

Authors:  David J Heal; Jane Gosden
Journal:  Int J Obes (Lond)       Date:  2022-01-07       Impact factor: 5.551

Review 2.  Single-Gene Determinants of Epilepsy Comorbidity.

Authors:  Jeffrey L Noebels
Journal:  Cold Spring Harb Perspect Med       Date:  2015-11-02       Impact factor: 6.915

Review 3.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

4.  Effects of lamotrigine on attention-deficit hyperactivity disorder in pediatric epilepsy patients.

Authors:  Seung-A Han; Eu Jeen Yang; Mi-Kyoung Song; Sun Jun Kim
Journal:  Korean J Pediatr       Date:  2017-06-22

Review 5.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

Review 6.  Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.

Authors:  David J Heal; Sharon L Smith
Journal:  J Psychopharmacol       Date:  2021-07-28       Impact factor: 4.562

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.